PROCEPT BioRobotics (MEX:PRCT) Institutional Ownership: 59.10% (As of Jun. 27, 2026)


MEX:PRCT PROCEPT BioRobotics Corp MEX:PRCT
54 GF Score
Price MXN358.45
GF Value MXN1,536.19
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PROCEPT BioRobotics Institutional Ownership?

PROCEPT BioRobotics MEX:PRCT 54 Institutional Ownership is 59.10% as of Jun. 27, 2026. GuruFocus rates MEX:PRCT with a GF Score™ of 54/100 and a GF Value™ of MXN1,536.19 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PROCEPT BioRobotics's institutional ownership is 59.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PROCEPT BioRobotics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PROCEPT BioRobotics's Float Percentage Of Total Shares Outstanding is 97.15%.

PROCEPT BioRobotics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for PROCEPT BioRobotics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PROCEPT BioRobotics Institutional Ownership Chart

PROCEPT BioRobotics Historical Data

The historical data trend for PROCEPT BioRobotics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 78.86 80.64 77.17 76.33 77.82 75.46 69.56 59.54 58.84 59.10
MEX:PRCT
54GF Score
PROCEPT BioRobotics Corp MEX:PRCT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PROCEPT BioRobotics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 59.10% mean?
PROCEPT BioRobotics (MEX:PRCT) has a Institutional Ownership of 59.10% as of Jun. 27, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PROCEPT BioRobotics and its competitors.
Is PROCEPT BioRobotics' Institutional Ownership too high?
PROCEPT BioRobotics' current Institutional Ownership is 59.10%. Overall, PROCEPT BioRobotics has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Institutional Ownership compare to ALMR and AHCO?
PROCEPT BioRobotics' Institutional Ownership of 59.10% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PROCEPT BioRobotics and its competitors. PROCEPT BioRobotics's current Institutional Ownership is 59.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (MEX:PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,536.19, compared to a current price of MXN358.45 — trading 76.7% below its estimated fair value. The current Institutional Ownership is 59.10%. PROCEPT BioRobotics' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For PROCEPT BioRobotics (MEX:PRCT), the current Institutional Ownership is 59.10% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PROCEPT BioRobotics (MEX:PRCT) Overvalued in 2026?

Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued. The current stock price of MXN358.45 is trading 76.7% below its estimated GF Value™ of MXN1,536.19. GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.

Key valuation signals for MEX:PRCT:

  • Institutional Ownership: 59.10%
  • GF Value™: MXN1,536.19 vs. price of MXN358.45 (76.7% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the MEX:PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PROCEPT BioRobotics Business Description

Other Exchanges PRCT:USA
Address 150 Baytech Drive, San Jose, CA, USA, 95134
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
54GF Score

Get the complete analysis for MEX:PRCT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN358.45
Price
MXN1,536.19
GF Value